Neuroplast
PrivateLast Round
Series B
Nov 17, 2021
Total Funding Raised
$15.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuroplast is a biotechnology company that develops the autologous stem cell platform product Neuro-Cells®, a treatment to combat neurodegeneration resulting from trauma, disease and ageing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuroplast Comparables
Compare Neuroplast with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regeneration Biomedical, Inc. | 79% | |
| Matricelf Ltd | 77% | |
| Brainstorm Cell Therapeutics Inc. | 77% |
Neuroplast Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 17, 2021 | ||||
| Series A | Feb 19, 2020 |
Neuroplast Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 819 Capital Partners | Series A |
| Brightlands Venture Partners | Series B, Series A |
| Lumana Invest | Series B |
| LIOF | Series B, Series A |
| Netherlands Enterprise Agency | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 17, 2026
Grew 33% QoQ from 9 to 12 employees.
- Apr 25, 2026
Grew 43% QoQ from 7 to 10 employees.
Neuroplast Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neuroplast's valuation, stock price, and market status.
Is Neuroplast a public or private company?
Neuroplast is a private company.
What is the current stock price of Neuroplast?
Neuroplast is a private company with no public stock price. No recent secondary market data is available.
How much is Neuroplast worth (valuation)?
Valuation information for Neuroplast is not publicly available.
Can I buy Neuroplast stock?
Neuroplast shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Neuroplast's last funding round?
Neuroplast's most recent funding round was Series B on November 17, 2021.
Who are the main investors in Neuroplast?
Key investors in Neuroplast include Lumana Invest.
Will Neuroplast IPO soon?
No public IPO plans have been announced for Neuroplast.
How can I track Neuroplast secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Neuroplast's secondary market activity and sign up for updates.